Wells Fargo’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,924
| Closed | -$2K | – | 7732 |
|
|
2020
Q4 | $2K | Sell |
2,924
-8,651
| -75% | -$5.34K | ﹤0.01% | 6311 |
|
|
2020
Q3 | $6K | Sell |
11,575
-6,462
| -36% | -$4.39K | ﹤0.01% | 6006 |
|
|
2020
Q2 | $13K | Sell |
18,037
-65,240
| -78% | -$51.7K | ﹤0.01% | 5802 |
|
|
2020
Q1 | $63K | Buy |
83,277
+15,570
| +23% | +$21.4K | ﹤0.01% | 5268 |
|
|
2019
Q4 | $101K | Buy |
67,707
+1,865
| +3% | +$2.8K | ﹤0.01% | 5294 |
|
|
2019
Q3 | $97K | Sell |
65,842
-8,456
| -11% | -$13.7K | ﹤0.01% | 5334 |
|
|
2019
Q2 | $96K | Sell |
74,298
-19,940
| -21% | -$36.7K | ﹤0.01% | 5326 |
|
|
2019
Q1 | $246K | Sell |
94,238
-9,753
| -9% | -$22.9K | ﹤0.01% | 4717 |
|
|
2018
Q4 | $172K | Buy |
103,991
+48,784
| +88% | +$137K | ﹤0.01% | 5013 |
|
|
2018
Q3 | $269K | Sell |
55,207
-7,227
| -12% | -$41K | ﹤0.01% | 4849 |
|
|
2018
Q2 | $391K | Buy |
62,434
+23,417
| +60% | +$175K | ﹤0.01% | 4640 |
|
|
2018
Q1 | $324K | Buy |
39,017
+2,680
| +7% | +$25.6K | ﹤0.01% | 4701 |
|
|
2017
Q4 | $370K | Sell |
36,337
-81,748
| -69% | -$784K | ﹤0.01% | 4607 |
|
|
2017
Q3 | $1.08M | Buy |
118,085
+63,832
| +118% | +$485K | ﹤0.01% | 3793 |
|
|
2017
Q2 | $396K | Buy |
54,253
+6,223
| +13% | +$47K | ﹤0.01% | 4366 |
|
|
2017
Q1 | $346K | Buy |
48,030
+27,174
| +130% | +$169K | ﹤0.01% | 4489 |
|
|
2016
Q4 | $122K | Sell |
20,856
-243
| -1% | -$1.64K | ﹤0.01% | 5049 |
|
|
2016
Q3 | $139K | Buy |
+21,099
| New | +$167K | ﹤0.01% | 4710 |
|
|
2016
Q2 | – | Sell |
-435
| Closed | -$5K | – | 6452 |
|
|
2016
Q1 | $5K | Buy |
435
+420
| +2,800% | +$4.43K | ﹤0.01% | 5878 |
|
|
2015
Q4 | $0 | Sell |
15
-8
| -35% | -$121 | ﹤0.01% | 6515 |
|
|
2015
Q3 | $0 | Buy |
+23
| New | +$507 | ﹤0.01% | 6558 |
|
Wells Fargo's NEOS Position: Q1 2021 in Review
Wells Fargo sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 2,924 shares — an estimated $2K sold.
Wells Fargo first reported a position in NEOS in Q3 2015 and held it in 21 quarters. The position peaked at $1.08M in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Wells Fargo reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Wells Fargo sold 2,924 Neos Therapeutics, Inc shares in Q1 2021, an estimated $2K.
- Wells Fargo first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 21 quarters.
- Wells Fargo's Neos Therapeutics, Inc position peaked at $1.08M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Wells Fargo's 13F filing for Q1 2021, filed 13 May 2021.